Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Biomaterials Science|May 8, 2024
Non-viral vector-based genome editing for cancer immunotherapyTianxu Fang, Guojun ChenBioactive Materials|August 1, 2025
Advances in cold atmospheric plasma therapy for cancerTianxu Fang, Zhitong Chen, Guojun ChenJournal of Nanobiotechnology|August 2, 2022
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editingTianxu Fang, Xiaona Cao, Mysha Ibnat, et al.Biomaterials|June 12, 2023
Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatmentTianxu Fang, Xiaona Cao, Bingzheng Shen, et al.Bioactive Materials|June 8, 2026
Lyophilized bacteria-infected tumor cells for targeted immunotherapy of lung metastases and associated fibrosisMo Chen, Yueyang Deng, Tianxu Fang, et al.AAPS Pharmscitech|September 7, 2019
Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral BioavailabilityYingxin Xu, Tianxu Fang, Yifan Yang, et al.Journal of Materials Chemistry. B|March 29, 2022
Supramolecular biomaterials for enhanced cancer immunotherapyHan Zhang, Jiafei Zhu, Tianxu Fang, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2026
Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodesYueyang Deng, Mo Chen, Tianxu Fang, et al.Bioactive Materials|November 29, 2023
Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockadeTianxu Fang, Xiaona Cao, Li Wang, et al.Advanced Materials (Deerfield Beach, Fla.)|March 13, 2026
Cold Atmospheric Plasma-Activated Decellularized Extracellular Matrix Gel as a Tumor-Infiltrating Immunoactivation Platform for Post-Surgical Cancer ImmunotherapyTianxu Fang, Mo Chen, Yueyang Deng, et al.Pageof 3